Three biotech stocks that have profited tremendously from their virtual monopolies are Alexion Pharmaceuticals (NASDAQ: ALXN), BioMarin Pharmaceutical (NASDAQ: BMRN), and Vertex Pharmaceuticals (NASDAQ: VRTX). Do these biotechs' market positions make them winners for investors over the long run?
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,